Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review
Triple-negative breast cancer (TNBC) is the subtype of breast cancer with the poorest outcomes, and is associated with a high risk of relapse and metastasis. The treatment choices for this malignancy have been confined to conventional chemotherapeutic agents, due to a lack of expression of the canon...
Main Authors: | Mina Hosseini, Simin Seyedpour, Behzad Khodaei, Amir-Hossein Loghman, Nasrin Seyedpour, Mohammad-Hossein Yazdi, Nima Rezaei |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/1/146 |
Similar Items
-
Modern Immunotherapy in the Treatment of Triple-Negative Breast Cancer
by: Jakub Wesolowski, et al.
Published: (2022-08-01) -
Update on Classic and Novel Approaches in Metastatic Triple-Negative Breast Cancer Treatment: A Comprehensive Review
by: Salvatore Greco, et al.
Published: (2023-06-01) -
Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021-08-01) -
Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021-05-01) -
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
by: Onyinyechi Obidiro, et al.
Published: (2023-06-01)